Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiantian Tao

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
The International Journal of Health Planning and Management|December 9, 2020
Factors associated with the choice of primary treatment at the community level among the middle-aged and elderly in ChinaTiantian Tao, Lili Hou, Rong Shao
Frontiers in Public Health|February 22, 2021
The Effects of Childhood Circumstances on Health in Middle and Later Life: Evidence From ChinaTiantian Tao, Rong Shao, Yuanjia Hu
Archives of Public Health = Archives Belges De Sante Publique|February 22, 2025
Wealth gradients in healthy aging: evidence from the 2011 and 2013 waves of the China Health and Retirement Longitudinal StudyTiantian Tao, Mengru Zhan, Xin Li, et al.
International Journal of Clinical Pharmacy|December 24, 2024
Whether temporal discounting is domain-specific between health outcomes and money: a systematic review and meta-analysisTiantian Tao, Junni Du, Yuyang Sun, et al.
Annals of Translational Medicine|December 5, 2022
Impact of the COVID-19 pandemic on clinical trials: a cross-sectional questionnaire study in ChinaYanhong Zhu, Yanjun Sun, Yan Jin, et al.
Journal of Global Health|December 17, 2022
Impact of the national drug price negotiation policy on the utilization, cost, and accessibility of anticancer medicines in China: A controlled interrupted time series studyLele Cai, Tiantian Tao, Hongtao Li, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 21, 2026
Physicians' preferences for direct-acting antivirals in the treatment of chronic hepatitis C: evidence from a discrete choice experiment in ChinaYan Li, Junni Du, Chenhui Tian, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 28, 2024
Comparison of the EQ-5D-Y and the CHU-9D instruments in a general child population based on self-reports and proxy-reportsYan Li, Yanqiu Chen, Jize Sun, et al.
Future Microbiology|November 18, 2024
Economic evaluation of treating invasive aspergillosis with isavuconazole, posaconazole and voriconazole in ChinaQiang Liu, Pingyu Chen, Dunming Xiao, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 22, 2026
Domain-specific discounting of health and money: implications for health technology assessmentJunni Du, Yi Cao, Yuxin Cai, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
The International Journal of Health Planning and Management|December 9, 2020
Factors associated with the choice of primary treatment at the community level among the middle-aged and elderly in ChinaTiantian Tao, Lili Hou, Rong Shao
Frontiers in Public Health|February 22, 2021
The Effects of Childhood Circumstances on Health in Middle and Later Life: Evidence From ChinaTiantian Tao, Rong Shao, Yuanjia Hu
Archives of Public Health = Archives Belges De Sante Publique|February 22, 2025
Wealth gradients in healthy aging: evidence from the 2011 and 2013 waves of the China Health and Retirement Longitudinal StudyTiantian Tao, Mengru Zhan, Xin Li, et al.
International Journal of Clinical Pharmacy|December 24, 2024
Whether temporal discounting is domain-specific between health outcomes and money: a systematic review and meta-analysisTiantian Tao, Junni Du, Yuyang Sun, et al.
Annals of Translational Medicine|December 5, 2022
Impact of the COVID-19 pandemic on clinical trials: a cross-sectional questionnaire study in ChinaYanhong Zhu, Yanjun Sun, Yan Jin, et al.
Journal of Global Health|December 17, 2022
Impact of the national drug price negotiation policy on the utilization, cost, and accessibility of anticancer medicines in China: A controlled interrupted time series studyLele Cai, Tiantian Tao, Hongtao Li, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 21, 2026
Physicians' preferences for direct-acting antivirals in the treatment of chronic hepatitis C: evidence from a discrete choice experiment in ChinaYan Li, Junni Du, Chenhui Tian, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 28, 2024
Comparison of the EQ-5D-Y and the CHU-9D instruments in a general child population based on self-reports and proxy-reportsYan Li, Yanqiu Chen, Jize Sun, et al.
Future Microbiology|November 18, 2024
Economic evaluation of treating invasive aspergillosis with isavuconazole, posaconazole and voriconazole in ChinaQiang Liu, Pingyu Chen, Dunming Xiao, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 22, 2026
Domain-specific discounting of health and money: implications for health technology assessmentJunni Du, Yi Cao, Yuxin Cai, et al.
Pageof 3